Skip to main content
. 2021 Apr 22;296:100705. doi: 10.1016/j.jbc.2021.100705

Figure 7.

Figure 7

Structure of the MEK1-KSR2-Trametinib complex. The overall structure of MEK1 (tan) binding to the KSR2 pseudokinase domain (gray; PDB 7jur; (107)). An inset view below illustrates the intimate relationship between the MEK1 activation loop and Trametinib, which is stabilized by KSR2.